UK Host Cell Protein Testing Market Size, Share, Trends & Forecast
uk host cell protein testing market is projected to grow from USD 69.0 million in 2024 to USD 120.0 million by 2035, registering a CAGR of 5.159% during 2025–2035. Increasing biopharmaceutical production, regulatory requirements, and demand for quality-control testing are supporting market development.
The UK’s growing biopharmaceutical research and development activity is creating demand for analytical testing solutions. Manufacturers of biologics require testing procedures to evaluate process-related impurities and support product quality throughout development and manufacturing.
ELISA-based assays are expected to lead the market in 2024, with a reported value of USD 25 million. PCR-based assays are also important because of their speed and sensitivity, while mass spectrometry-based assays provide high specificity and detailed protein characterization capabilities.
Biopharmaceutical companies represent a major end-user group, while contract research organizations provide specialized testing services to pharmaceutical and biotechnology companies. Increasing outsourcing, regulatory compliance requirements, and demand for advanced analytical services are creating opportunities across the UK market.
Gain a competitive edge with insightful market reports: